Hard Sell, Evan Hughes
🛈 Nu vindem cărți — comparăm prețuri. Comanda o plasezi direct pe site-ul librăriei.
„Hard Sell, Evan Hughes” se găsește acum doar ca exemplar second-hand, la 18,98 RON. Cel mai mic preț este 18,98 RON la Anticariat Ex Libris (exemplar second-hand). Verifică toate ofertele mai jos și comandă direct de la librăria aleasă. Prețul a crescut recent, așa că merită comparat înainte de comandă.
Oferta găsită
Prețurile se actualizează zilnic. Ultima verificare a ofertei principale: 06.11.2026. Confirmă prețul final și livrarea pe site-ul librăriei.
Despre carte
The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial. “A fast-paced and maddening account. Until I read The Hard Sell, about the outrageous behavior of an obscure drug company, I hadn’t appreciated the full extent of the filth or the dark stain the opioid sector has left on the entire industry. What’s most surprising and powerful about The Hard Sell is not one company’s criminality—we’ve grown inured to corporations behaving badly—as much as how institutionalized these practices were across the modern drug industry.” —New York Times Book Review John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. It was the early 2000s, a boom time for painkillers, and he developed a novel formulation of fentanyl, the most potent opioid on the market. Kapoor, a brilliant immigrant scientist with relentless business instincts, was eager to make the most of his innovation. He gathered around him an ambitious group of young lieutenants. His head of sales—an unstable and unmanageable leader, but a genius of persuasion—built a team willing to pull every lever to close a sale, going so far as to recruit an exotic dancer ready to scrape her way up. They zeroed in on the eccentric and suspect doctors receptive to their methods. Employees at headquarters did their part by deceiving insurance companies. The drug was a niche product, approved only for cancer patients in dire condition, but the company’s leadership pushed it more widely, and together they turned Insys into a Wall Street sensation. But several insiders reached their breaking point and blew the whistle. They sparked a sprawling investigation that would le
Evoluția prețului
Cărți similare
"Are we there yet?": insights on how to lead by design
de la 31,99 RON
Help your kids with study skills: a unique step-by-step visual guide
de la 36,99 RON
The complete idiot's guide to Facebook marketing
de la 27,99 RON
Brand Mysticism, Steven Grasse, Aaron Goldfarb
de la 33,99 RON
Communication For International Business, Rus Slater
de la 13,99 RON
Berlin Mini Map and Guide
de la 21,99 RON
The Hundred Story Home
de la 18,98 RON
Covering
de la 18,98 RON